The IPO List
HomeListingsBlogsAboutJoin WhatsApp CommunityWhatsApp(Opens in a new tab)

The IPO List

Your trusted platform for IPO tracking and investment insights.

Quick Links

IPOsIPO ArchiveBlogsGMP AccuracyMethodologyAboutContact

Legal

Privacy PolicyTerms of ServiceDisclaimer

© 2026 The IPO List. All rights reserved.

  1. Home/
  2. IPO Calendar/
  3. Sai Life Sciences IPO
Sai Life Sciences
MainboardListed

Sai Life Sciences IPO

Bidding 11-13 Dec 2024, price band ₹522–549, lot 27 shares.

+2.04%
listing gain
OverviewAllotment

Grey Market Premium Trend

GMP last updated: 2 Apr 2026, 8:37 AM IST

₹11
Final GMP
2.04%
Actual Listing Gain
2.0%
GMP-Implied Gain
₹522 - ₹549
Price Band

GMP History

DateGMP (₹)Est. Listing Price (₹)Est. Listing Gain
4 Oct₹11₹5602.00%
3 Oct₹32₹5815.83%
2 Oct₹17₹5663.10%
1 Oct₹10₹5591.82%
30 Sep₹8₹5571.46%

IPO timeline

  1. Issue open date
    11 Dec 2024
  2. Issue close date
    13 Dec 2024
  3. UPI mandate deadline
    13 Dec 2024
  4. Allotment finalization
    16 Dec 2024
  5. Refund initiation
    17 Dec 2024
  6. Share credit
    17 Dec 2024
  7. Listing date
    18 Dec 2024
  8. Mandate end date
    28 Dec 2024
  9. Lock-in end date for anchor investors (50%)
    15 Jan 2025
  10. Lock-in end date for anchor investors (remaining)
    16 Mar 2025

Sai Life Sciences IPO Allotment Status

Allotment date:16 Dec 2024
Registrar:Kfin Technologies Limited
  1. Open the registrar's allotment page from the link below.
  2. Select Sai Life Sciences from the list of companies.
  3. Enter your PAN, application number or demat account (DP/Client ID).
  4. Submit to see how many shares you were allotted.
Check allotment on Kfin Technologies(Opens in a new tab)BSE application status check(Opens in a new tab)

After allotment

Refund / mandate release:17 Dec 2024
Shares credited to demat:17 Dec 2024
Listing:18 Dec 2024
💸

IPO Subscription Status

CategoryTimesEst. Allotment Chances*
HNIs (Total)2.4540.8%
bHNI3.5628.1%
sHNI0.24100%
QIBs1.73-
Retail0.12100%
Total1.08-

*Rough estimate: 1 ÷ times subscribed. Retail and HNI allotment is by lottery, so actual odds depend on the number of applications.

Last updated: 27 March'26 04:44PM

Quick Stats

Issue Size:3043cr
Lot Size:27 shares
Min Investment:₹14,823
P/E Ratio:72.19

About the Company

Sai Life Sciences Limited, established in 1999, is a contract research, development, and manufacturing organization (CRDMO) providing services in drug discovery, development, and manufacturing. The company offers capabilities in chemistry, manufacturing, and control (CMC) and contract research (CRO) for small-molecule new chemical entities. It serves over 280 pharmaceutical companies and operates globally, with facilities in the US, UK, and India. The company employs over 2,300 scientific staff and has received multiple regulatory approvals from authorities including the USFDA and CDSCO.

Strengths

  • Integrated Indian CRDMO offering discovery, development, and manufacturing services.
  • Portfolio includes 50 late-phase and commercial products as of September 30, 2024.
  • Diverse mix of commercial drugs and under-development molecules with blockbuster potential.
  • CRDMO model enables proximity-based development and manufacturing in India.
  • Broad customer base, including top global pharmaceutical companies.

Risks

  • Dependence on biotechnology and pharmaceutical customers subject to market and funding risks.
  • R&D outcomes may fail to meet customer expectations, leading to project discontinuation.
  • Low success rate in drug development impacts overall financial performance.
  • Risks from international operations, including delays and regulatory challenges.
  • Loss-making subsidiaries may adversely impact overall financials.
  • Pricing pressure from customers may affect margins and profitability.
  • High working capital requirements could strain financial resources.
  • No proceeds from the Offer for Sale portion will benefit the company.

Sai Life Sciences IPO – Frequently Asked Questions

  • The price band for the Sai Life Sciences IPO is set at ₹522 to ₹549 per share.
  • The Sai Life Sciences IPO opens on December 11, 2024 and closes on December 13, 2024.
  • The tentative listing date for the Sai Life Sciences IPO is December 18, 2024.
  • The last recorded Grey Market Premium (GMP) for the Sai Life Sciences IPO before listing was ₹11 (2%). GMP is unofficial and is not a guarantee of the listing price.
  • The Sai Life Sciences IPO listed on December 18, 2024 with a listing gain of 2.04% over its issue price.
  • The Sai Life Sciences IPO allotment date is December 16, 2024. Once it is finalised, check your status with your PAN or application number on the website of the registrar, Kfin Technologies Limited. Issues listed on BSE can also be checked on the BSE application status page.
  • You can apply for the Sai Life Sciences IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Sai Life Sciences, enter lot quantity and UPI ID, then approve the mandate.
  • The lot size for the Sai Life Sciences IPO is 27 shares. Investors must apply for at least one lot (i.e., 27 shares), which costs ₹14,823 at the upper price band.

Related IPOs

Open and upcoming

  • Friends Union for Energising Lives (FUEL)Bidding 11-20 Nov 2026
    Open
  • Crystal Crop ProtectionBidding 18-20 Nov 2026
    Open
  • Mahanadi CoalfieldsBidding 19-23 Nov 2026
    Upcoming
  • Watrana RentalsBidding 19-23 Nov 2026
    Upcoming

Recent mainboard listings

  • Bombay Coated & Special SteelsListed 5 Nov 2026
    +10.98%
  • M.K.Sons Fine JewelsListed 4 Nov 2026
    +5.56%
  • BLS PolymersListed 3 Nov 2026
    +65.33%
  • SFC Environmental TechnologiesListed 3 Nov 2026
    +7.61%
  • EAAA India AlternativesListed 2 Nov 2026
    +0.63%
  • Jio PlatformsListed 28 Oct 2026
    +21.36%

All IPOs that opened in December 2024